| 000 | 01731 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518034641.0 | ||
| 264 | 0 | _c20191217 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1434-9949 | ||
| 024 | 7 |
_a10.1007/s10067-019-04557-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDuarte, Ana Catarina | |
| 245 | 0 | 0 |
_aRituximab in connective tissue disease-associated interstitial lung disease. _h[electronic resource] |
| 260 |
_bClinical rheumatology _cJul 2019 |
||
| 300 |
_a2001-2009 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
| 650 | 0 | 4 |
_aConnective Tissue Diseases _xcomplications |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIdiopathic Interstitial Pneumonias _xdiagnosis |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRituximab _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVital Capacity _xdrug effects |
| 700 | 1 | _aCordeiro, Ana | |
| 700 | 1 | _aFernandes, Bruno Miguel | |
| 700 | 1 | _aBernardes, Miguel | |
| 700 | 1 | _aMartins, Patrícia | |
| 700 | 1 | _aCordeiro, Inês | |
| 700 | 1 | _aSantiago, Tânia | |
| 700 | 1 | _aSeixas, Maria Inês | |
| 700 | 1 | _aRibeiro, Ana Roxo | |
| 700 | 1 | _aSantos, Maria José | |
| 773 | 0 |
_tClinical rheumatology _gvol. 38 _gno. 7 _gp. 2001-2009 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10067-019-04557-7 _zAvailable from publisher's website |
| 999 |
_c29619528 _d29619528 |
||